Industry Research Reports

Home > Reports > Service & Software > Global Cell therapy platform Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Cell therapy platform Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Service & Software

Published Date: 2025-11-27

Pages: 77 Pages

Report ld: 4956196

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Cell therapy platform Market Size(US$)

CAGR 2025-2031

14.2%

Market Size,2031

USD 10,419

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 4,697 million

Market Forecast in 2031(Value)

US$ 10,419 million

CAGR

14.2%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Cell therapy platform market size was US$ 4137 million in 2024 and is forecast to a readjusted size of US$ 10419 million by 2031 with a CAGR of 14.2% during the forecast period 2025-2031.

A cell therapy platform refers to a comprehensive system built around the research, development, production, and clinical translation of cell-based therapeutic products (such as CAR-T, TCR-T, NK cells, and stem cells). It includes the technical and equipment support for the entire process, from cell source acquisition, isolation and purification, gene editing, expansion and culture, quality control, cryopreservation and transportation, to clinical drug delivery. This platform improves the safety, consistency, and scalable production capabilities of cell therapy through standardized, automated, and closed-loop process systems, accelerating the transition of cell therapy from the laboratory to clinical applications.

The downstream of cell therapy platforms primarily serves hospitals and clinical departments, cell therapy companies, biopharmaceutical companies, and research institutions, and is applied to the clinical translation of cell preparations, personalized treatment implementation, outsourced process development, and support for large-scale clinical trials. Due to the high technical barriers, complex production systems, and stringent quality standards of cell therapy, platform services command a significant professional premium; therefore, downstream orders typically have high profit margins, with a general gross profit margin of around 56%.

As the forefront of modern biomedical technology, the cell therapy platform is leading to major breakthroughs in personalized medicine and regenerative medicine. It provides innovative treatment options for a variety of intractable diseases, especially in the treatment of cancer, genetic diseases and immune system diseases. With the continuous development of gene editing technology, cell expansion processes and biomaterials, the cell therapy platform will further optimize the preparation, storage and transportation of cells, and improve the safety and effectiveness of treatment. Despite the technical complexity, high costs and regulatory challenges, the rapid development of the cell therapy platform indicates that it is expected to provide more patients with customized and precise treatment options in the future, pushing the medical field to new heights.

The global Cell therapy platform market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.

MARKET SEGMENTATION

By Company

Novartis
Gilead Sciences
Regeneron Pharmaceuticals
Takeda Pharmaceuticals
Roche
Bluebird Bio
Cellectis
Sangamo Therapeutics
Fate Therapeutics

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Autologous Cell Therapy Platform
Allogeneic Cell Therapy Platform
Others

Segment by Application

General Hospital
Specialized Hospital
Others

Segment by Category

Immunotherapy Platform
Stem Cell Therapy Platform
Genetically Modified Cell Therapy Platform

Segment by Division

Manually Operated Platform
Semi-Automated Cell Therapy Platform
Fully Automated Closed-Loop Cell Therapy Platform

biaoTi CHAPTER OUTLINE

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).

Chapter 2: Quantitative analysis of Cell therapy platform market size and growth potential at global, regional, and country levels.

Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).

Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Allogeneic Cell Therapy Platform in China).

Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Specialized Hospital in India).

Chapter 6: Regional revenue breakdown by company, type, application and customer.

Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.

Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 9: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Cell therapy platform value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031

1.2.2 Autologous Cell Therapy Platform

1.2.3 Allogeneic Cell Therapy Platform

1.2.4 Others

1.3 Market by Application

1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031

1.3.2 General Hospital

1.3.3 Specialized Hospital

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cell therapy platform Market Perspective (2020-2031)

2.2 Global Market Size by Region: 2020 VS 2024 VS 2031

2.3 Global Cell therapy platform Revenue Market Share by Region (2020-2025)

2.4 Global Cell therapy platform Revenue Forecast by Region (2026-2031)

2.5 Major Region and Emerging Market Analysis

2.5.1 North America Cell therapy platform Market Size and Prospective (2020-2031)

2.5.2 Europe Cell therapy platform Market Size and Prospective (2020-2031)

2.5.3 Asia-Pacific Cell therapy platform Market Size and Prospective (2020-2031)

2.5.4 Latin America Cell therapy platform Market Size and Prospective (2020-2031)

2.5.5 Middle East & Africa Cell therapy platform Market Size and Prospective (2020-2031)

3 Breakdown Data by Type

3.1 Global Cell therapy platform Historic Market Size by Type (2020-2025)

3.2 Global Cell therapy platform Forecasted Market Size by Type (2026-2031)

3.3 Different Types Cell therapy platform Representative Players

4 Breakdown Data by Application

4.1 Global Cell therapy platform Historic Market Size by Application (2020-2025)

4.2 Global Cell therapy platform Forecasted Market Size by Application (2026-2031)

4.3 New Sources of Growth in Cell therapy platform Application

5 Competition Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Cell therapy platform Players by Revenue (2020-2025)

5.1.2 Global Cell therapy platform Revenue Market Share by Players (2020-2025)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Cell therapy platform Revenue

5.4 Global Cell therapy platform Market Concentration Analysis

5.4.1 Global Cell therapy platform Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Cell therapy platform Revenue in 2024

5.5 Global Key Players of Cell therapy platform Head office and Area Served

5.6 Global Key Players of Cell therapy platform, Product and Application

5.7 Global Key Players of Cell therapy platform, Date of Enter into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments and Downstream

6.1.1 North America Cell therapy platform Revenue by Company (2020-2025)

6.1.2 North America Market Size by Type

6.1.2.1 North America Cell therapy platform Market Size by Type (2020-2025)

6.1.2.2 North America Cell therapy platform Market Share by Type (2020-2025)

6.1.3 North America Market Size by Application

6.1.3.1 North America Cell therapy platform Market Size by Application (2020-2025)

6.1.3.2 North America Cell therapy platform Market Share by Application (2020-2025)

6.1.4 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments and Downstream

6.2.1 Europe Cell therapy platform Revenue by Company (2020-2025)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Cell therapy platform Market Size by Type (2020-2025)

6.2.2.2 Europe Cell therapy platform Market Share by Type (2020-2025)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Cell therapy platform Market Size by Application (2020-2025)

6.2.3.2 Europe Cell therapy platform Market Share by Application (2020-2025)

6.2.4 Europe Market Trend and Opportunities

6.3 Asia-Pacific Market: Players, Segments and Downstream

6.3.1 Asia-Pacific Cell therapy platform Revenue by Company (2020-2025)

6.3.2 Asia-Pacific Market Size by Type

6.3.2.1 Asia-Pacific Cell therapy platform Market Size by Type (2020-2025)

6.3.2.2 Asia-Pacific Cell therapy platform Market Share by Type (2020-2025)

6.3.3 Asia-Pacific Market Size by Application

6.3.3.1 Asia-Pacific Cell therapy platform Market Size by Application (2020-2025)

6.3.3.2 Asia-Pacific Cell therapy platform Market Share by Application (2020-2025)

6.3.4 Asia-Pacific Market Trend and Opportunities

6.4 Latin America Market: Players, Segments and Downstream

6.4.1 Latin America Cell therapy platform Revenue by Company (2020-2025)

6.4.2 Latin America Market Size by Type

6.4.2.1 Latin America Cell therapy platform Market Size by Type (2020-2025)

6.4.2.2 Latin America Cell therapy platform Market Share by Type (2020-2025)

6.4.3 Latin America Market Size by Application

6.4.3.1 Latin America Cell therapy platform Market Size by Application (2020-2025)

6.4.3.2 Latin America Cell therapy platform Market Share by Application (2020-2025)

6.4.4 Latin America Market Trend and Opportunities

6.5 Middle East & Africa Market: Players, Segments and Downstream

6.5.1 Middle East & Africa Cell therapy platform Revenue by Company (2020-2025)

6.5.2 Middle East & Africa Market Size by Type

6.5.2.1 Middle East & Africa Cell therapy platform Market Size by Type (2020-2025)

6.5.2.2 Middle East & Africa Cell therapy platform Market Share by Type (2020-2025)

6.5.3 Middle East & Africa Market Size by Application

6.5.3.1 Middle East & Africa Cell therapy platform Market Size by Application (2020-2025)

6.5.3.2 Middle East & Africa Cell therapy platform Market Share by Application (2020-2025)

6.5.4 Middle East & Africa Market Trend and Opportunities

7 Key Players Profiles

7.1 Novartis

7.1.1 Novartis Company Details

7.1.2 Novartis Business Overview

7.1.3 Novartis Cell therapy platform Introduction

7.1.4 Novartis Revenue in Cell therapy platform Business (2020-2025)

7.1.5 Novartis Recent Development

7.2 Gilead Sciences

7.2.1 Gilead Sciences Company Details

7.2.2 Gilead Sciences Business Overview

7.2.3 Gilead Sciences Cell therapy platform Introduction

7.2.4 Gilead Sciences Revenue in Cell therapy platform Business (2020-2025)

7.2.5 Gilead Sciences Recent Development

7.3 Regeneron Pharmaceuticals

7.3.1 Regeneron Pharmaceuticals Company Details

7.3.2 Regeneron Pharmaceuticals Business Overview

7.3.3 Regeneron Pharmaceuticals Cell therapy platform Introduction

7.3.4 Regeneron Pharmaceuticals Revenue in Cell therapy platform Business (2020-2025)

7.3.5 Regeneron Pharmaceuticals Recent Development

7.4 Takeda Pharmaceuticals

7.4.1 Takeda Pharmaceuticals Company Details

7.4.2 Takeda Pharmaceuticals Business Overview

7.4.3 Takeda Pharmaceuticals Cell therapy platform Introduction

7.4.4 Takeda Pharmaceuticals Revenue in Cell therapy platform Business (2020-2025)

7.4.5 Takeda Pharmaceuticals Recent Development

7.5 Roche

7.5.1 Roche Company Details

7.5.2 Roche Business Overview

7.5.3 Roche Cell therapy platform Introduction

7.5.4 Roche Revenue in Cell therapy platform Business (2020-2025)

7.5.5 Roche Recent Development

7.6 Bluebird Bio

7.6.1 Bluebird Bio Company Details

7.6.2 Bluebird Bio Business Overview

7.6.3 Bluebird Bio Cell therapy platform Introduction

7.6.4 Bluebird Bio Revenue in Cell therapy platform Business (2020-2025)

7.6.5 Bluebird Bio Recent Development

7.7 Cellectis

7.7.1 Cellectis Company Details

7.7.2 Cellectis Business Overview

7.7.3 Cellectis Cell therapy platform Introduction

7.7.4 Cellectis Revenue in Cell therapy platform Business (2020-2025)

7.7.5 Cellectis Recent Development

7.8 Sangamo Therapeutics

7.8.1 Sangamo Therapeutics Company Details

7.8.2 Sangamo Therapeutics Business Overview

7.8.3 Sangamo Therapeutics Cell therapy platform Introduction

7.8.4 Sangamo Therapeutics Revenue in Cell therapy platform Business (2020-2025)

7.8.5 Sangamo Therapeutics Recent Development

7.9 Fate Therapeutics

7.9.1 Fate Therapeutics Company Details

7.9.2 Fate Therapeutics Business Overview

7.9.3 Fate Therapeutics Cell therapy platform Introduction

7.9.4 Fate Therapeutics Revenue in Cell therapy platform Business (2020-2025)

7.9.5 Fate Therapeutics Recent Development

8 Cell therapy platform Market Dynamics

8.1 Cell therapy platform Industry Trends

8.2 Cell therapy platform Market Drivers

8.3 Cell therapy platform Market Challenges

8.4 Cell therapy platform Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Cell therapy platform Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Cell therapy platform Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Market Cell therapy platform Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Cell therapy platform Revenue (US$ Million) Market Share by Region (2020-2025)

Table 5. Global Cell therapy platform Revenue Share by Region (2020-2025)

Table 6. Global Cell therapy platform Revenue (US$ Million) Forecast by Region (2026-2031)

Table 7. Global Cell therapy platform Revenue Share Forecast by Region (2026-2031)

Table 8. Global Cell therapy platform Market Size by Type (2020-2025) & (US$ Million)

Table 9. Global Cell therapy platform Revenue Market Share by Type (2020-2025)

Table 10. Global Cell therapy platform Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 11. Global Cell therapy platform Revenue Market Share by Type (2026-2031)

Table 12. Representative Players of Each Type

Table 13. Global Cell therapy platform Market Size by Application (2020-2025) & (US$ Million)

Table 14. Global Cell therapy platform Revenue Market Share by Application (2020-2025)

Table 15. Global Cell therapy platform Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 16. Global Cell therapy platform Revenue Market Share by Application (2026-2031)

Table 17. New Sources of Growth in Cell therapy platform Application

Table 18. Global Cell therapy platform Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Cell therapy platform Market Share by Players (2020-2025)

Table 20. Global Top Cell therapy platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell therapy platform as of 2024)

Table 21. Ranking of Global Top Cell therapy platform Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Cell therapy platform Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Cell therapy platform, Headquarters and Area Served

Table 24. Global Key Players of Cell therapy platform, Product and Application

Table 25. Global Key Players of Cell therapy platform, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Cell therapy platform Revenue by Company (2020-2025) & (US$ Million)

Table 28. North America Cell therapy platform Revenue Market Share by Company (2020-2025)

Table 29. North America Cell therapy platform Market Size by Type (2020-2025) & (US$ Million)

Table 30. North America Cell therapy platform Market Size by Application (2020-2025) & (US$ Million)

Table 31. Europe Cell therapy platform Revenue by Company (2020-2025) & (US$ Million)

Table 32. Europe Cell therapy platform Revenue Market Share by Company (2020-2025)

Table 33. Europe Cell therapy platform Market Size by Type (2020-2025) & (US$ Million)

Table 34. Europe Cell therapy platform Market Size by Application (2020-2025) & (US$ Million)

Table 35. Asia-Pacific Cell therapy platform Revenue by Company (2020-2025) & (US$ Million)

Table 36. Asia-Pacific Cell therapy platform Revenue Market Share by Company (2020-2025)

Table 37. Asia-Pacific Cell therapy platform Market Size by Type (2020-2025) & (US$ Million)

Table 38. Asia-Pacific Cell therapy platform Market Size by Application (2020-2025) & (US$ Million)

Table 39. Latin America Cell therapy platform Revenue by Company (2020-2025) & (US$ Million)

Table 40. Latin America Cell therapy platform Revenue Market Share by Company (2020-2025)

Table 41. Latin America Cell therapy platform Market Size by Type (2020-2025) & (US$ Million)

Table 42. Latin America Cell therapy platform Market Size by Application (2020-2025) & (US$ Million)

Table 43. Middle East & Africa Cell therapy platform Revenue by Company (2020-2025) & (US$ Million)

Table 44. Middle East & Africa Cell therapy platform Revenue Market Share by Company (2020-2025)

Table 45. Middle East & Africa Cell therapy platform Market Size by Type (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Cell therapy platform Market Size by Application (2020-2025) & (US$ Million)

Table 47. Novartis Company Details

Table 48. Novartis Business Overview

Table 49. Novartis Cell therapy platform Product

Table 50. Novartis Revenue in Cell therapy platform Business (2020-2025) & (US$ Million)

Table 51. Novartis Recent Development

Table 52. Gilead Sciences Company Details

Table 53. Gilead Sciences Business Overview

Table 54. Gilead Sciences Cell therapy platform Product

Table 55. Gilead Sciences Revenue in Cell therapy platform Business (2020-2025) & (US$ Million)

Table 56. Gilead Sciences Recent Development

Table 57. Regeneron Pharmaceuticals Company Details

Table 58. Regeneron Pharmaceuticals Business Overview

Table 59. Regeneron Pharmaceuticals Cell therapy platform Product

Table 60. Regeneron Pharmaceuticals Revenue in Cell therapy platform Business (2020-2025) & (US$ Million)

Table 61. Regeneron Pharmaceuticals Recent Development

Table 62. Takeda Pharmaceuticals Company Details

Table 63. Takeda Pharmaceuticals Business Overview

Table 64. Takeda Pharmaceuticals Cell therapy platform Product

Table 65. Takeda Pharmaceuticals Revenue in Cell therapy platform Business (2020-2025) & (US$ Million)

Table 66. Takeda Pharmaceuticals Recent Development

Table 67. Roche Company Details

Table 68. Roche Business Overview

Table 69. Roche Cell therapy platform Product

Table 70. Roche Revenue in Cell therapy platform Business (2020-2025) & (US$ Million)

Table 71. Roche Recent Development

Table 72. Bluebird Bio Company Details

Table 73. Bluebird Bio Business Overview

Table 74. Bluebird Bio Cell therapy platform Product

Table 75. Bluebird Bio Revenue in Cell therapy platform Business (2020-2025) & (US$ Million)

Table 76. Bluebird Bio Recent Development

Table 77. Cellectis Company Details

Table 78. Cellectis Business Overview

Table 79. Cellectis Cell therapy platform Product

Table 80. Cellectis Revenue in Cell therapy platform Business (2020-2025) & (US$ Million)

Table 81. Cellectis Recent Development

Table 82. Sangamo Therapeutics Company Details

Table 83. Sangamo Therapeutics Business Overview

Table 84. Sangamo Therapeutics Cell therapy platform Product

Table 85. Sangamo Therapeutics Revenue in Cell therapy platform Business (2020-2025) & (US$ Million)

Table 86. Sangamo Therapeutics Recent Development

Table 87. Fate Therapeutics Company Details

Table 88. Fate Therapeutics Business Overview

Table 89. Fate Therapeutics Cell therapy platform Product

Table 90. Fate Therapeutics Revenue in Cell therapy platform Business (2020-2025) & (US$ Million)

Table 91. Fate Therapeutics Recent Development

Table 92. Cell therapy platform Market Trends

Table 93. Cell therapy platform Market Drivers

Table 94. Cell therapy platform Market Challenges

Table 95. Cell therapy platform Market Restraints

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

List of Figures

Figure 1. Cell therapy platform Product Picture

Figure 2. Global Cell therapy platform Market Share by Type: 2024 VS 2031

Figure 3. Autologous Cell Therapy Platform Features

Figure 4. Allogeneic Cell Therapy Platform Features

Figure 5. Others Features

Figure 6. Global Cell therapy platform Market Share by Application: 2024 VS 2031

Figure 7. General Hospital

Figure 8. Specialized Hospital

Figure 9. Others

Figure 10. Cell therapy platform Report Years Considered

Figure 11. Global Cell therapy platform Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Cell therapy platform Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Cell therapy platform Revenue Market Share by Region: 2020 VS 2024

Figure 14. North America Cell therapy platform Revenue (US$ Million) Growth Rate (2020-2031)

Figure 15. Europe Cell therapy platform Revenue (US$ Million) Growth Rate (2020-2031)

Figure 16. Asia-Pacific Cell therapy platform Revenue (US$ Million) Growth Rate (2020-2031)

Figure 17. Latin America Cell therapy platform Revenue (US$ Million) Growth Rate (2020-2031)

Figure 18. Middle East & Africa Cell therapy platform Revenue (US$ Million) Growth Rate (2020-2031)

Figure 19. Global Cell therapy platform Market Share by Players in 2024

Figure 20. Global Top Cell therapy platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell therapy platform as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Cell therapy platform Revenue in 2024

Figure 22. North America Cell therapy platform Market Share by Type (2020-2025)

Figure 23. North America Cell therapy platform Market Share by Application (2020-2025)

Figure 24. Europe Cell therapy platform Market Share by Type (2020-2025)

Figure 25. Europe Cell therapy platform Market Share by Application (2020-2025)

Figure 26. Asia-Pacific Cell therapy platform Market Share by Type (2020-2025)

Figure 27. Asia-Pacific Cell therapy platform Market Share by Application (2020-2025)

Figure 28. Latin America Cell therapy platform Market Share by Type (2020-2025)

Figure 29. Latin America Cell therapy platform Market Share by Application (2020-2025)

Figure 30. Middle East & Africa Cell therapy platform Market Share by Type (2020-2025)

Figure 31. Middle East & Africa Cell therapy platform Market Share by Application (2020-2025)

Figure 32. Novartis Revenue Growth Rate in Cell therapy platform Business (2020-2025)

Figure 33. Gilead Sciences Revenue Growth Rate in Cell therapy platform Business (2020-2025)

Figure 34. Regeneron Pharmaceuticals Revenue Growth Rate in Cell therapy platform Business (2020-2025)

Figure 35. Takeda Pharmaceuticals Revenue Growth Rate in Cell therapy platform Business (2020-2025)

Figure 36. Roche Revenue Growth Rate in Cell therapy platform Business (2020-2025)

Figure 37. Bluebird Bio Revenue Growth Rate in Cell therapy platform Business (2020-2025)

Figure 38. Cellectis Revenue Growth Rate in Cell therapy platform Business (2020-2025)

Figure 39. Sangamo Therapeutics Revenue Growth Rate in Cell therapy platform Business (2020-2025)

Figure 40. Fate Therapeutics Revenue Growth Rate in Cell therapy platform Business (2020-2025)

Figure 41. Bottom-up and Top-down Approaches for This Report

Figure 42. Data Triangulation

Figure 43. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Cell therapy platform market size from 2025 to 2031? zhanKai

The annual compound growth rate of the global Cell therapy platform market is 14.2% 2025 to 2031.

Which companies rank high in the global Cell therapy platform market? shouQi

What was the global market size of Cell therapy platform in 2031? shouQi

What was the global market size of Cell therapy platform in 2025? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Global Cell therapy platform Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Cell therapy platform market is projected to grow from US$ 4697 million in 2025 to US$ 11750 million by 2032, at a CAGR of 14.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 125
USD 4900.00
(Single User License)
Global Cell therapy platform Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cell therapy platform market size was US$ 4697 million in 2025 and is forecast to reach a readjusted size of US$ 11750 million by 2032 with a CAGR of 14.2% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 80
USD 4250.00
(Single User License)
Cell therapy platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cell therapy platform was estimated to be worth US$ 4697 million in 2025 and is projected to reach US$ 11750 million, growing at a CAGR of 14.2% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 92
USD 3950.00
(Single User License)
Global Cell therapy platform Market Research Report 2026
The global Cell therapy platform market was valued at US$ 4697 million in 2025 and is anticipated to reach US$ 11750 million by 2032, at a CAGR of 14.2% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 106
USD 2900.00
(Single User License)
Global Cell therapy platform Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cell therapy platform market is projected to grow from US$ 4137 million in 2024 to US$ 10419 million by 2031, at a CAGR of 14.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-27
Pages: 130
USD 4900.00
(Single User License)
Cell therapy platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cell therapy platform was estimated to be worth US$ 4137 million in 2024 and is forecast to a readjusted size of US$ 10419 million by 2031 with a CAGR of 14.2% during the forecast period 2025-2031.
Published Date: 2025-11-27
Pages: 88
USD 3950.00
(Single User License)
Global Cell therapy platform Market Research Report 2025
The global market for Cell therapy platform was valued at US$ 4137 million in the year 2024 and is projected to reach a revised size of US$ 10419 million by 2031, growing at a CAGR of 14.2% during the forecast period.
Published Date: 2025-11-27
Pages: 79
USD 2900.00
(Single User License)
Global Cell therapy platform Market Research Report 2024
A cell therapy platform refers to a comprehensive system that supports the research, development, processing, preparation and application of cells through a series of technologies, equipment and processes. The platform is used to develop and produce living cell-based therapies, including immune cell therapy, stem cell therapy and gene-modified cell therapy. These therapies are widely used in the fields of cancer, genetic diseases, immune system diseases and tissue repair, and aim to achieve therapeutic effects by enhancing or repairing the patient's cell function. The platform usually covers multiple links such as cell separation, amplification, gene editing, quality control and clinical application.
Published Date: 2024-10-26
Pages: 72
USD 2900.00
(Single User License)
Global and United States Cell therapy platform Market Report & Forecast 2024-2030
A cell therapy platform refers to a comprehensive system that supports the research, development, processing, preparation and application of cells through a series of technologies, equipment and processes. The platform is used to develop and produce living cell-based therapies, including immune cell therapy, stem cell therapy and gene-modified cell therapy. These therapies are widely used in the fields of cancer, genetic diseases, immune system diseases and tissue repair, and aim to achieve therapeutic effects by enhancing or repairing the patient's cell function. The platform usually covers multiple links such as cell separation, amplification, gene editing, quality control and clinical application.
Published Date: 2024-10-26
Pages: 96
USD 4350.00
(Single User License)
Global Cell therapy platform Market Insights, Forecast to 2030
A cell therapy platform refers to a comprehensive system that supports the research, development, processing, preparation and application of cells through a series of technologies, equipment and processes. The platform is used to develop and produce living cell-based therapies, including immune cell therapy, stem cell therapy and gene-modified cell therapy. These therapies are widely used in the fields of cancer, genetic diseases, immune system diseases and tissue repair, and aim to achieve therapeutic effects by enhancing or repairing the patient's cell function. The platform usually covers multiple links such as cell separation, amplification, gene editing, quality control and clinical application.
Published Date: 2024-10-26
Pages: 123
USD 4900.00
(Single User License)

Global Cell therapy platform Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Cell therapy platform market is projected to grow from US$ 4697 million in 2025 to US$ 11750 million by 2032, at a CAGR of 14.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 125
USD 4900.00 (Single User License)
Global Cell therapy platform Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cell therapy platform market size was US$ 4697 million in 2025 and is forecast to reach a readjusted size of US$ 11750 million by 2032 with a CAGR of 14.2% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 80
USD 4250.00 (Single User License)
Cell therapy platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cell therapy platform was estimated to be worth US$ 4697 million in 2025 and is projected to reach US$ 11750 million, growing at a CAGR of 14.2% from 2026 to 2032.
Published: 2026-01-08
Pages: 92
USD 3950.00 (Single User License)
Global Cell therapy platform Market Research Report 2026
The global Cell therapy platform market was valued at US$ 4697 million in 2025 and is anticipated to reach US$ 11750 million by 2032, at a CAGR of 14.2% from 2026 to 2032.
Published: 2026-01-08
Pages: 106
USD 2900.00 (Single User License)
Global Cell therapy platform Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cell therapy platform market is projected to grow from US$ 4137 million in 2024 to US$ 10419 million by 2031, at a CAGR of 14.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-27
Pages: 130
USD 4900.00 (Single User License)
Cell therapy platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cell therapy platform was estimated to be worth US$ 4137 million in 2024 and is forecast to a readjusted size of US$ 10419 million by 2031 with a CAGR of 14.2% during the forecast period 2025-2031.
Published: 2025-11-27
Pages: 88
USD 3950.00 (Single User License)
Global Cell therapy platform Market Research Report 2025
The global market for Cell therapy platform was valued at US$ 4137 million in the year 2024 and is projected to reach a revised size of US$ 10419 million by 2031, growing at a CAGR of 14.2% during the forecast period.
Published: 2025-11-27
Pages: 79
USD 2900.00 (Single User License)
Global Cell therapy platform Market Research Report 2024
A cell therapy platform refers to a comprehensive system that supports the research, development, processing, preparation and application of cells through a series of technologies, equipment and processes. The platform is used to develop and produce living cell-based therapies, including immune cell therapy, stem cell therapy and gene-modified cell therapy. These therapies are widely used in the fields of cancer, genetic diseases, immune system diseases and tissue repair, and aim to achieve therapeutic effects by enhancing or repairing the patient's cell function. The platform usually covers multiple links such as cell separation, amplification, gene editing, quality control and clinical application.
Published: 2024-10-26
Pages: 72
USD 2900.00 (Single User License)
Global and United States Cell therapy platform Market Report & Forecast 2024-2030
A cell therapy platform refers to a comprehensive system that supports the research, development, processing, preparation and application of cells through a series of technologies, equipment and processes. The platform is used to develop and produce living cell-based therapies, including immune cell therapy, stem cell therapy and gene-modified cell therapy. These therapies are widely used in the fields of cancer, genetic diseases, immune system diseases and tissue repair, and aim to achieve therapeutic effects by enhancing or repairing the patient's cell function. The platform usually covers multiple links such as cell separation, amplification, gene editing, quality control and clinical application.
Published: 2024-10-26
Pages: 96
USD 4350.00 (Single User License)
Global Cell therapy platform Market Insights, Forecast to 2030
A cell therapy platform refers to a comprehensive system that supports the research, development, processing, preparation and application of cells through a series of technologies, equipment and processes. The platform is used to develop and produce living cell-based therapies, including immune cell therapy, stem cell therapy and gene-modified cell therapy. These therapies are widely used in the fields of cancer, genetic diseases, immune system diseases and tissue repair, and aim to achieve therapeutic effects by enhancing or repairing the patient's cell function. The platform usually covers multiple links such as cell separation, amplification, gene editing, quality control and clinical application.
Published: 2024-10-26
Pages: 123
USD 4900.00 (Single User License)